The gateway activity for leukocyte trafficking was found to be disrupted in AD mouse models as a consequence of decreased CP interferon-γ (IFN-γ) signaling, which affected the induction of leukocyte trafficking determinants [76,77]. Here, CP is linked to Alzheimer disease.